Screener
Roivant Sciences ROIV EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Other expense, net | 2,130 | 11,208 |
| Loss before income taxes | (294,564) | (269,262) |
| Income tax (benefit) expense | (3,958) | 4,649 |
| Net loss | (290,606) | (273,911) |
| Net loss attributable to noncontrolling interests | (100,769) | (50,556) |
| Net loss attributable to Roivant Sciences Ltd. | $(189,837) | $(223,355) |
| Net loss per common share—basic and diluted | $(0.26) | $(0.33) |
| Weighted average shares outstanding—basic and diluted | 720,776,739 | 680,286,922 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Roivant Sciences's EPS (diluted)?
- Roivant Sciences (ROIV) reported EPS (diluted) of -$0.26 in Q2 2026.
- How has Roivant Sciences's EPS (diluted) changed year-over-year?
- Roivant Sciences's EPS (diluted) increased by 21.2% year-over-year, from -$0.33 to -$0.26.
- What is the long-term trend for Roivant Sciences's EPS (diluted)?
- Over 3 years (2021 to 2024), Roivant Sciences's EPS (diluted) has grown at a -41.5% compound annual growth rate (CAGR), from -$1.25 to -$0.25.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Roivant Sciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude